Aeterna zentaris Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Aeterna zentaris Contact Number

Contact Aeterna Zentaris

2 hours ago Zentaris.com Show details

843-900-3223

CONTACT US. USA Aeterna Zentaris, Inc. 315 Sigma Drive Summerville, SC 29486 Phone: 843-900-3223

Category: Contact SupportShow more

AEterna Zentaris Crunchbase Company Profile & Funding

6 hours ago Crunchbase.com Show details

418-652-8525

Company Type For Profit. Contact Email [email protected] Phone Number 418-652-8525. AEterna Zentaris Inc. is a drug development company specialized in oncology and endocrine therapy. The Company's product pipeline encompasses compounds at all stages of development, from drug discovery through marketed products.

Occupation: President And Chief Executive Officer
Location: Quebec
Founded: Jul 01, 2007

Category: Contact NumberShow more

Specialty Biopharmaceutical Company Aeterna Zentaris

5 hours ago Zentaris.com Show details

Aeterna Zentaris is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Company’s lead product, macimorelin, is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of AGHD.

Category: Contact NumberShow more

Aeterna Zentaris Gmbh Frankfurt 60314 (Frankfurt

6 hours ago Lb.kompass.com Show details

Contact - AEterna Zentaris GmbH. Weismüllerstraße 50 60314 Frankfurt. * This phone number available for 3 min is not the recipient’s number but a number from a service which will put you through to that person. AEterna Zentaris GmbH Download the executives list from the same business.

Category: Contact NumberShow more

Company Information Aeterna Zentaris

4 hours ago Zentaris.com Show details

Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing pipeline to address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), primary hypoparathyroidism and amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).

Category: Contact NumberShow more

AEterna Zentaris Inc. Profile SEDAR

3 hours ago Sedar.com Show details

AEterna Zentaris Inc. Profile. AEterna Zentaris Inc. Mailing Address: c/o Norton Rose Fulbright Canada LLP. 222 Bay Street, Suite 3000. Toronto, Ontario. M5K 1E7. Head Office Address: 315 Sigma Drive.

Category: Contact NumberShow more

Aeterna Zentaris, Inc. Securities Litigation

3 hours ago Aeternasecuritieslitigation.com Show details

The estimated average cost for such fees and expense, if the Court approves Lead Counsel’s fee and expense application, is $0.0513 per affected share of. Aeterna common stock. This does not include Notice and Administration Costs, which are expected to range from $250,000 to $350,000 and are paid from the Settlement Fund. 2. 6.

Category: Contact NumberShow more

AEterna Zentaris Company Profile Office Locations

3 hours ago Craft.co Show details

AEterna Zentaris has 11 employees across 3 locations and $3.65 M in annual revenue in FY 2020. See insights on AEterna Zentaris including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

Macimorelin Aeterna Zentaris European Medicines Agency

8 hours ago Ema.europa.eu Show details

Macimorelin Aeterna Zentaris can only be obtained with a prescription and its use must be supervised by a healthcare professional experienced in diagnosing growth hormone deficiency. For more information about using Macimorelin Aeterna Zentaris, see the package leaflet or contact your doctor or pharmacist.

Category: Contact NumberShow more

Macimorelin Aeterna Zentaris INNmacimorelin

2 hours ago Ema.europa.eu Show details

The applicant Aeterna Zentaris GmbH submitted on 26 October 2017 an application for marketing authorisation to the European Medicines Agency (EMA) for Macimorelin Aeterna Zentaris , through the centralised procedure un der Article 3 (2) (a) of Regulation (EC) No 726/2004. The eligibility to the

Category: Contact NumberShow more

Aeterna Zentaris Inc. (Form: 6K, Received: 05/25/2011 12

8 hours ago Content.edgar-online.com Show details

Commission file number 0-30752 ÆTERNA ZENTARIS INC. 1405, boul. du Parc-Technologique Québec, Québec Canada, G1P 4P5 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under …

Category: Contact NumberShow more

AEterna Zentaris Inc. (AEZS) Company Profile & Overview

6 hours ago Stockanalysis.com Show details

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, a peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone …

Category: Contact NumberShow more

Investors Aeterna Zentaris

4 hours ago Zentaris.com Show details

Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing pipeline to address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), primary hypoparathyroidism and amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).

Category: Contact NumberShow more

Aeterna Zentaris Inc. (Form: 20F, Received: 04/01/2019 06

Just Now Content.edgar-online.com Show details

In May 2004, we changed our name to Aeterna Zentaris Inc. and on May 11, 2007, Zentaris GmbH was renamed Aeterna Zentaris GmbH ("AEZS Germany"). AEZS Germany conducts our drug development efforts. In September 2007, we incorporated Aeterna Zentaris, Inc. under the laws of Delaware.

Category: Contact NumberShow more

Aeterna Zentaris Inc. (Form: F3, Received: 08/01/2019 09

4 hours ago Content.edgar-online.com Show details

(843) 900-3211

(Address and telephone number of Registrant’s principal executive offices) Michael V. Ward President and Chief Executive Officer Aeterna Zentaris, Inc., 315 Sigma Drive Summerville, South Carolina 29486 (843) 900-3211 (Name, address, and telephone number of agent for service) Copies to:

Category: Contact NumberShow more

AEterna Zentaris GmbH, Frankfurt a. Main, Germany

6 hours ago Northdata.com Show details

Contact person and contact details. Our partner Echobot provides you with publicly available contacts for B2B companies like this one and other 12 million companies from UK & German speaking Markets. Find your right person to contact at AEterna Zentaris GmbH.

Category: Contact NumberShow more

About Aeterna Zentaris

2 hours ago Zentaris.com Show details

Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing pipeline to address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), primary hypoparathyroidism and amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).

Category: Contact NumberShow more

Aeterna Zentaris, Inc.

6 hours ago Plainsite.org Show details

Aeterna Zentaris, Inc. 1405, Boul. Du Parc-technologique Quebec G1p 4p5 CANADA

Category: Contact NumberShow more

AEterna Zentaris Number of Employees 20062021 AEZS

3 hours ago Macrotrends.net Show details

AEterna Zentaris number of employees from 2006 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. AEterna Zentaris Inc. is a biopharmaceutical company focused on endocrine therapy and oncology.

Category: Contact NumberShow more

AEterna Zentaris Inc. (AEZS): The number for Jenene on

2 hours ago Investorshub.advfn.com Show details

Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc. - 9/8/2021 8:00:00 AM: Aeterna Zentaris Reports Second Quarter 2021 Financial Results and Provides Pipeline Program Updates GlobeNewswire Inc. - 8/4/2021 4:05:00 PM

Category: Contact NumberShow more

Aeterna Zentaris Engages Dr. Michael Levy to Support

7 hours ago Pressviewer.com Show details

Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing preclinical pipeline to potentially address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), hypoparathyroidism and amyotrophic lateral sclerosis (ALS; Lou Gehrig

Category: Support NumberShow more

Nominees Aeterna Zentaris, Inc. Securities Litigation

9 hours ago Aeternasecuritieslitigation.com Show details

nominees. if you are a broker or other nominee who purchased aeterna zentaris, inc. (“aeterna” or the “company”) securities on a u.s. exchange or in a u.s. transaction during the period from august 30, 2011 through november 6, 2014, both dates inclusive (the “class period”), and who did not sell such securities prior to november 6, 2014, then within seven (7) calendar days of your

Category: Contact NumberShow more

AETERNA ZENTARIS INC. : Shareholders Board Members

Just Now Marketscreener.com Show details

The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc. Number of employees : 11 people. Sales per Business

Category: Contact NumberShow more

Aeterna Zentaris (AEZS) Recent Earnings

8 hours ago Earningswhispers.com Show details

Aeterna Zentaris (AEZS) reported a Quarter June 2021 loss of $0.02 per share on revenue of $0.6 million.. Revenue grew 780.9% on a year-over-year basis. AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology, endocrinology and women' health. Earnings Whisper.

Category: Contact NumberShow more

Www.sec.gov

7 hours ago Sec.gov Show details

Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing preclinical pipeline to potentially address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), hypoparathyroidism and amyotrophic lateral sclerosis (ALS; Lou Gehrig

Category: Contact NumberShow more

Aeterna Zentaris Inc. (AEZS) Stock Price, Quote, News

Just Now Channelchek.com Show details

Aeterna Zentaris Inc. is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Company’s lead product, macimorelin, is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).

Category: Contact NumberShow more

Aeterna Zentaris Reports First Quarter 2021 Financial

4 hours ago Finance.yahoo.com Show details

Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing pipeline to address unmet medical needs across a number of …

Category: Contact NumberShow more

Aeterna Zentaris Announces Results of 2021 Annual Meeting

5 hours ago Finance.yahoo.com Show details

(833) 475-8247

Investor Contact: Jenene ThomasJTC TeamT (US): +1 (833) 475-8247E: [email protected] About Aeterna Zentaris Inc. Aeterna Zentaris is a specialty biopharmaceutical company developing and

Category: Contact NumberShow more

Aeterna Zentaris Announces the Selection of a Development

4 hours ago Finance.yahoo.com Show details

We are in contact with CMOs to establish the GMP manufacturing process to prepare material for the required toxicology and safety assessment of AEZS-150. About Aeterna Zentaris Inc. Aeterna

Category: Contact NumberShow more

Aeterna Zentaris Inc. (AEZS) 10K Annual Reports & 10Q SEC

6 hours ago Last10k.com Show details

View differences made from one year to another to evaluate Aeterna Zentaris Inc.'s financial trajectory Sample 10-K Year-over-Year (YoY) Comparison Compare this 40-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aeterna Zentaris

Category: Contact NumberShow more

Aeterna Zentaris Reports Fourth Quarter and Full Year 2020

5 hours ago Finance.yahoo.com Show details

CHARLESTON, S.C., March 25, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing

Category: Contact NumberShow more

Aeterna Zentaris Granted 180Day Extension by Nasdaq to

5 hours ago Nasdaq.com Show details

--Aeterna Zentaris Inc., a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that it has received a …

Category: Contact NumberShow more

Aeterna Zentaris to Present at the Q2 Virtual Investor Summit

1 hours ago Finance.yahoo.com Show details

Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing pipeline to address unmet medical needs across a number of …

Category: Contact NumberShow more

Aeterna Zentaris Number of Employees (NASDAQ:AEZS)

3 hours ago Macroaxis.com Show details

Based on the recorded statements, Aeterna Zentaris is currently employing 12.0 people. This is 99.89% lower than that of the Healthcare sector and 97.76% lower than that of the Biotechnology industry. The number of employees for all United States stocks is 99.94% higher than that of the company. Aeterna Zentaris is number one stock in number of

Category: Contact NumberShow more

Analysis of Current Aeterna Zentaris Long Line Candle

4 hours ago Macroaxis.com Show details

Investors typically determine Aeterna Zentaris value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aeterna Zentaris' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Category: Contact NumberShow more

Aeterna Zentaris Commences Pivotal Phase 3 DETECTTrial

7 hours ago Pressviewer.com Show details

Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing preclinical pipeline to potentially address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), hypoparathyroidism and an undisclosed neurodegenerative disease.

Category: Contact NumberShow more

Aeterna Zentaris Stock Forecast 2021 Naive Prediction

9 hours ago Macroaxis.com Show details

Although open interest is a measure utilized in the options markets, it could be used to forecast Aeterna Zentaris' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will.Since open interest Aeterna Zentaris' options reflect these daily shifts, investors could use the patterns of these changes to develop long

Category: Contact NumberShow more

Aeterna Zentaris Inc : AEZS Stock Price Quote at Ally Invest

6 hours ago Research.tradeking.com Show details

AEterna Zentaris Announces Sale of 6.9 Million Shares 5:40PM ET 2/16/2021 MT Newswires. AEterna Zentaris (AEZS) announced after the close on Tuesday that it has entered into an underwriting agreement with H.C. Wainwright to purchase

Category: Contact NumberShow more

Aeterna Zentaris Target Price for 2022 AEZS

3 hours ago Macroaxis.com Show details

Aeterna Zentaris' current and average target prices are 0.60 and 4.50, respectively. The current price of Aeterna Zentaris is the price at which Aeterna Zentaris is currently trading. On the other hand, Aeterna Zentaris' target price is what analysts think the stock is worth or could sell for in the future.

Category: Contact NumberShow more

Aeterna Zentaris Inc. (NASDAQ: AEZS): Aiming For A Higher

3 hours ago Stocksregister.com Show details

According to the data, the short interest in Aeterna Zentaris Inc. (AEZS) stood at 3.33% of shares outstanding as of Sep 14, 2021; the number of short shares registered in Aug 12, 2021 reached 4.51 million. The stock has risen by 46.18% since the beginning of the year, thereby showing the potential of a further growth.

Category: Contact NumberShow more

Lawsuit: AEterna Zentaris Inc, AEZS Securities Fraud

7 hours ago Lawyersandsettlements.com Show details

Company: AEterna Zentaris Inc, Ticker Symbol: AEZS Class Period: Feb-3-10 to Apr-1-12 Date Filed: Jun-15-12 Lead Plaintiff Deadline: Aug-14-12 Court: Southern District of New York Allegations: New

Category: Contact NumberShow more

Aeterna Stock Price History for September (NASDAQ:AEZS

9 hours ago Macroaxis.com Show details

If you would invest 88.00 in Aeterna Zentaris on June 30, 2021 and sell it today you would lose (27.00) from holding Aeterna Zentaris or give up 30.68% of portfolio value over 90 days. Aeterna Zentaris is currently does not generate positive expected returns and assumes 3.5417% risk (volatility on return distribution) over the 90 days horizon.

Category: Contact NumberShow more

AEZS: Dividend Date & History for Aeterna Zentaris Inc

2 hours ago Dividend.com Show details

Dividend Capture Strategy for AEZS. Dividend capture strategy is based on AEZS’s historical data. Past performance is no guarantee of future results. Step 1: Buy AEZS shares 1 day before the ex-dividend date. purchase date (estimate) N/A. Upcoming Ex-dividend date.

Category: Contact NumberShow more

Aeterna Zentaris Inc. (AEZS) stock has a potential for

5 hours ago Bovnews.com Show details

The share price of Aeterna Zentaris Inc. (NASDAQ:AEZS) raised 0.13% to close Monday’s market session at $0.61, higher as compared to yesterday’s close. The stock price fluctuated between $0.5972 and $0.6124 throughout the trading session with the volume trading being 1183318 shares, which represented a significant variation when compared to

Category: Contact NumberShow more

A Great Bargain Stock You Could Consider Is Aeterna

1 hours ago Marketingsentinel.com Show details

Aeterna Zentaris Inc. (NASDAQ:AEZS)’s Major holders. Insiders own 0.07% of the company shares, while shares held by institutions stand at 3.91% with a share float percentage of 3.91%. Investors are also buoyed by the number of investors in a company, with Aeterna Zentaris Inc. having a total of 36 institutions that hold shares in the company.

Category: Contact NumberShow more

LI v. AETERNA ZENTARIS, INC. et al

3 hours ago Law360.com Show details

Parties, docket activity and news coverage of federal case LI v. AETERNA ZENTARIS, INC. et al, case number 3:14-cv-07081, from New Jersey Court.

Category: Contact NumberShow more

AETERNA ZENTARIS ANNOUNCES DISTRIBUTION AGREEMENT …

7 hours ago Bloomberg.com Show details

Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support

Category: Contact NumberShow more

Aeterna Zentaris Announces the Selection of a Development

4 hours ago Apnews.com Show details

Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing pipeline to address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), primary hypoparathyroidism and neurodegenerative disease.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Amazon
Abbvie
Aia
Asml
Apple
Att
Amgen
Adobe
Aptar
Acc
Adidas
Aak
Aes
Asx